CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-20 | Mauch Robert P. President & CEO | Sale 10b5-1 | −5,097 | $326.80 | $1.7M | 37,940 |
| 2025-10-20 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,763 | 15,051 | ||
| 2025-10-01 | Campbell Elizabeth S Executive Vice President | Sale 10b5-1 | −1,886 | $313.28 | $591K | 12,824.14 |
| 2025-09-18 | Mauch Robert P. President & CEO | Option exercise 10b5-1 | +3,763 | $86.09 | $324K | 44,371 |
| 2025-09-18 | Mauch Robert P. President & CEO | Sale 10b5-1 | −5,097 | $290.00 | $1.5M | 39,274 |
| 2025-09-18 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,763 | 18,814 | ||
| 2025-09-16 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +29,350 | $86.09 | $2.5M | 337,262.67 |
| 2025-09-16 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −31,350 | $289.86 | $9.1M | 305,912.67 |
| 2025-09-16 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −29,350 | 58,699 | ||
| 2025-08-19 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +12,579 | $86.09 | $1.1M | 322,491.67 |
| 2025-08-19 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −14,579 | $289.98 | $4.2M | 307,912.67 |
| 2025-08-19 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −12,579 | 88,049 | ||
| 2025-08-18 | Mauch Robert P. President & CEO | Option exercise 10b5-1 | +3,225 | $86.09 | $278K | 45,576 |
| 2025-08-18 | Mauch Robert P. President & CEO | Sale 10b5-1 | −4,968 | $293.53 | $1.5M | 40,608 |
| 2025-08-18 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,225 | 22,577 | ||
| 2025-08-01 | Baumann Werner Director | Grant or award | +126 | $288.35 | $36K | 3,022 |
| 2025-08-01 | Tyler Lauren M Director | Grant or award | +105 | $288.35 | $30K | 2,980 |
| 2025-08-01 | NALLY DENNIS M Director | Grant or award | +122 | $288.35 | $35K | 13,373 |
| 2025-07-22 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +12,578 | $86.09 | $1.1M | 324,490.67 |
| 2025-07-22 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −14,578 | $292.67 | $4.3M | 309,912.67 |
Page 9 of 40 · 797 trades